Bengaluru’s Pibit.AI has secured $7 million in its Series A funding round, led by Stellaris Venture Partners and joined by Y Combinator and Arali Ventures.
This fresh capital injection will accelerate the growth of Cure, Pibit.AI’s AI-powered underwriting automation platform, and support deepening R&D, new risk model development, and global expansion efforts.
Who Is Pibit.AI?
Pibit.AI is transforming commercial insurance underwriting by automating laborious, manual workflows using specialized AI models.
Founded by Akash Agarwal, the company addresses a critical industry pain point: fragmented data silos and inefficient manual data extraction that bog down insurers’ operations.
Its flagship platform Cure streamlines document intake, extracts underwriting data with high accuracy, and delivers decision-ready risk assessments, helping insurers save weeks of processing time per policy.
Funding & Metrics Overview
| Metric | Details |
|---|---|
| Series A Amount | $7 million |
| Lead Investors | Stellaris Venture Partners, Y Combinator, Arali Ventures |
| Core Product | Cure underwriting automation platform |
| Market Focus | US, expanding to Europe and India |
| Growth Target | 3x revenue increase in 2026 |
| Key Strength | High-accuracy domain-specific AI models |
Why Investors Are Betting on Pibit.AI?
This Series A round comes amid growing demand for domain-specific AI tools that solve real industry bottlenecks.
Pibit.AI’s trusted AI system drives superior data accuracy, which is crucial for underwriting decisions. Investors see strong product-market fit as the company scales beyond the US—which remains the largest market—to Europe and India.
The funding will expand Cure’s capabilities while pushing into more advanced risk modeling for underdeveloped markets.
With enterprise insurers increasingly adopting automated modules and full underwriting platforms, Pibit.AI is poised for rapid revenue growth, targeting a 3x increase in the coming year.
Important Funding Details
Who led the Series A round?
Stellaris Venture Partners led, with support from Y Combinator and Arali Ventures.
How will Pibit.AI use the capital?
To boost R&D, build new risk models, expand Cure’s platform adoption, and grow internationally.
What is Pibit.AI’s market focus?
Primarily the US commercial insurance market, with plans for Europe and India next.
Connect With Pibit.AI
| Platform | Link |
|---|---|
| Website | pibit.ai |
| linkedin.com/company/pibitai | |
| Twitter(X) | @Pibit_ai |
Pibit.AI’s Series A highlights the growing investor confidence in AI solutions targeting deeply specialized industry workflows.
The coming year will be critical as the startup scales globally and enhances its AI underwriting precision, carving out a significant role in insurtech’s AI evolution.
